Fondaparinux sodium: a review of its use in the management of acute coronary syndromes. - Wikidata - awgldk - TriplyDB

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

http://www.wikidata.org/entity/Q37142019

about

Factor Xa inhibitors for acute coronary syndromes Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function.Spotlight on fondaparinux sodium in acute coronary syndromes.Comparative evaluation of efficacy, safety and haemostatic parameters of enoxaparin and fondaparinux in unstable coronary artery disease.Fondaparinux: a pharmacoeconomic review of its use in the management of non-ST-segment elevation acute coronary syndrome.Cardiovascular drug therapy in the elderly: benefits and challenges.Use of recombinant factor VIIa (NovoSeven®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux

P2860

Q24234760-445B60A0-FB87-414F-BD33-5A9C32778D6E Q33460885-91FA9EAC-A621-4979-87CE-1396605B765A Q37322290-0F21EC3A-E4C1-40B7-9F86-B0815420421D Q37611996-E80113A2-22A9-4972-8EBE-A0869DB0C62B Q37771326-F262E97C-685E-4E8C-A487-F0D8FEB01116 Q37803337-F5164AE2-2191-4F3A-B3C3-8CCD88201BAD Q58088700-59D16D89-41CC-4155-96A3-C8CA823B8B87

P2860

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

http://www.wikidata.org/entity/Q37142019

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@en

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@nl

type

label

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@en

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@nl

prefLabel

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@en

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@nl

P1433

Q37142019-0E1CEA87-73EE-4264-8D9C-9CAFEB9001D3

P1476

Q37142019-CC8D4CA6-B66E-4F7E-9D36-6E0DCBEAF115

P2093

Q37142019-82A48387-AF8B-40D3-A86E-1C6CE5A5BE69

Q37142019-FD06CAA1-AB3D-4E82-87BA-57873E8CC9FD

P2860

Q37142019-2411217D-CAC5-47DA-A48E-0989761505CD

Q37142019-2AC1FB4A-E631-4795-BF55-4248EB42D85E

Q37142019-2BC2B9CD-FD84-4212-B372-F86A5E79485A

Q37142019-35B612BA-B539-44CB-BC9B-36618266A0A0

Q37142019-38B5EB0B-7EB1-44F0-9F62-A2FB4DE25C3B

Q37142019-4E764670-49D3-4F9D-A217-C7428A606C78

Q37142019-52F9F797-9F56-4E80-A460-7DABA7CA1292

Q37142019-63005B97-0586-48CE-AE32-F2C4AE9EFEDA

Q37142019-718F47A3-293B-4D11-9F3B-CC145863536D

Q37142019-74DDD002-208D-4209-A374-98C594C477C3

P2888

Q37142019-B5FD5D30-815A-4FEB-B340-C01F89A6E3E0

P304

Q37142019-FEAA89E0-4F82-4114-A7D5-A4A7D4D505A8

P31

Q37142019-7A5EBCE0-EAB1-42D5-AFB2-D974803A1503

P356

Q37142019-EB216E44-4A3D-4BF9-A42A-C2D183D49052

P433

Q37142019-13E75C71-946D-4EA7-B71D-40AA55776164

P478

Q37142019-A8B3E269-C812-4AE1-982E-754E5D5E4294

P50

Q37142019-0E25106C-083D-4972-9509-BD646C0EAF9D

Q37142019-BA9B0432-CD1B-40B3-9E5F-87ECA3771B1F

P577

Q37142019-26909E7A-8B9D-4CA6-BC2C-9D7922B03572

P698

Q37142019-EBAEDC61-A1D7-4099-A733-2163D0DB9680

P356

P1433

American journal of cardiovascular drugs

P1476

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

@en

P2093

Jennifer S Orman

http://www.w3.org/2001/XMLSchema#string

Stephanie K A Blick

http://www.w3.org/2001/XMLSchema#string

P2860

Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)

Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers

Evidence-based medical therapy of patients with acute coronary syndromes

New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.

Inhibition of Factor Xa : a potential target for the development of new anticoagulants.

Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism.

Early management of ST elevation myocardial infarction: a review of practice.

P2888

P304

113-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03256588

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Antona J Wagstaff

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18422394

http://www.w3.org/2001/XMLSchema#string